Loading your workspacePreparing the page and its market data.
Loading the chart…
| Outcome | Chance | 24h | 1 week | Bid · Ask | 24h volume | Ends |
|---|---|---|---|---|---|---|
| O/U 2.5 | 100% | +49 pts | +47 pts | >99¢ · 100¢ (<1¢) | — | ended |
| O/U 3.5 | 0% | −28 pts | −31 pts | — · <1¢ | — | ended |
| O/U 1.5 | 100% | +24 pts | +23 pts | >99¢ · 100¢ (<1¢) | — | ended |
| AS Omónoia Leukosías (-2.5) | 100% | +94 pts | +96 pts | >99¢ · 100¢ (<1¢) | — | ended |
| Both Teams to Score | 0% | −56 pts | −56 pts | — · <1¢ | — | ended |
| 1st Half O/U 1.5 | 0% | −33 pts | −34 pts | — · <1¢ | — | ended |
| O/U 4.5 | 0% | −13 pts | −14 pts | — · <1¢ | — | ended |
| O/U 6.5 | 0% | −2 pts | −28 pts | — · <1¢ | — | ended |
| O/U 5.5 | 0% | −5 pts | −6 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías (-1.5) | 100% | +84 pts | +86 pts | >99¢ · 100¢ (<1¢) | — | ended |
| NK Celje (-1.5) | 0% | −16 pts | −17 pts | — · <1¢ | — | ended |
| O/U 0.5 | 100% | +7 pts | +6 pts | >99¢ · 100¢ (<1¢) | — | ended |
| 1st Half O/U 0.5 | 100% | +30 pts | +29 pts | >99¢ · 100¢ (<1¢) | — | ended |
| AS Omónoia Leukosías O/U 0.5 | 100% | +25 pts | +41 pts | >99¢ · 100¢ (<1¢) | — | ended |
| AS Omónoia Leukosías 1st Half O/U 0.5 | 100% | +56 pts | +50 pts | >99¢ · 100¢ (<1¢) | — | ended |
| NK Celje O/U 0.5 | 0% | −75 pts | −60 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías (-3.5) | 0% | −2 pts | −7 pts | — · <1¢ | — | ended |
| NK Celje O/U 2.5 | 0% | −15 pts | −44 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías O/U 1.5 | 100% | +61 pts | +50 pts | >99¢ · 100¢ (<1¢) | — | ended |
| NK Celje (-3.5) | 0% | −2 pts | −8 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías (-5.5) | 0% | −43 pts | −8 pts | — · <1¢ | — | ended |
| NK Celje O/U 1.5 | 0% | −38 pts | −45 pts | — · <1¢ | — | ended |
| NK Celje (-5.5) | 0% | −43 pts | −45 pts | — · <1¢ | — | ended |
| 1st Half O/U 3.5 | 0% | −4 pts | −26 pts | — · <1¢ | — | ended |
| NK Celje (-4.5) | 0% | −2 pts | −45 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías (-4.5) | 0% | −6 pts | −3 pts | — · <1¢ | — | ended |
| NK Celje (-2.5) | 0% | −5 pts | −5 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías O/U 2.5 | 100% | +85 pts | +64 pts | >99¢ · 100¢ (<1¢) | — | ended |
| O/U 7.5 | 0% | −1 pts | −10 pts | — · <1¢ | — | ended |
| O/U 8.5 | 0% | — | −6 pts | — · <1¢ | — | ended |
| Both Teams to Score in First Half | 0% | −20 pts | −41 pts | — · <1¢ | — | ended |
| 1st Half O/U 2.5 | 0% | −11 pts | −11 pts | — · <1¢ | — | ended |
| 1st Half O/U 4.5 | 0% | −46 pts | −26 pts | — · <1¢ | — | ended |
| NK Celje O/U 3.5 | 0% | −45 pts | −48 pts | — · <1¢ | — | ended |
| NK Celje O/U 4.5 | 0% | −47 pts | −48 pts | — · <1¢ | — | ended |
| NK Celje O/U 5.5 | 0% | −47 pts | −49 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías O/U 3.5 | 0% | −4 pts | −48 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías O/U 4.5 | 0% | −47 pts | −35 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías O/U 5.5 | 0% | −47 pts | −48 pts | — · <1¢ | — | ended |
| NK Celje 1st Half O/U 0.5 | 0% | −45 pts | −50 pts | — · <1¢ | — | ended |
| NK Celje 1st Half O/U 1.5 | 0% | −12 pts | −50 pts | — · <1¢ | — | ended |
| NK Celje 1st Half O/U 2.5 | 0% | −50 pts | −49 pts | — · <1¢ | — | ended |
| NK Celje 1st Half O/U 3.5 | 0% | −46 pts | −49 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías 1st Half O/U 1.5 | 0% | −12 pts | −37 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías 1st Half O/U 2.5 | 0% | −46 pts | −49 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías 1st Half O/U 3.5 | 0% | −46 pts | — | — · <1¢ | — | ended |
| Both Teams to Score in Second Half | 0% | −28 pts | −41 pts | — · <1¢ | — | ended |
| 2nd Half O/U 0.5 | 100% | +23 pts | +19 pts | >99¢ · 100¢ (<1¢) | — | ended |
| 2nd Half O/U 1.5 | 100% | +55 pts | +54 pts | >99¢ · 100¢ (<1¢) | — | ended |
| 2nd Half O/U 2.5 | 0% | −20 pts | −18 pts | — · <1¢ | — | ended |
| 2nd Half O/U 3.5 | 0% | −30 pts | −49 pts | — · <1¢ | — | ended |
| 2nd Half O/U 4.5 | 0% | −40 pts | −49 pts | — · <1¢ | — | ended |
| NK Celje 2nd Half O/U 0.5 | 0% | −52 pts | — | — · <1¢ | — | ended |
| NK Celje 2nd Half O/U 1.5 | 0% | −20 pts | −50 pts | — · <1¢ | — | ended |
| NK Celje 2nd Half O/U 2.5 | 0% | −46 pts | −49 pts | — · <1¢ | — | ended |
| NK Celje 2nd Half O/U 3.5 | 0% | −49 pts | — | — · <1¢ | — | ended |
| AS Omónoia Leukosías 2nd Half O/U 0.5 | 100% | +45 pts | +50 pts | >99¢ · 100¢ (<1¢) | — | ended |
| AS Omónoia Leukosías 2nd Half O/U 1.5 | 100% | +81 pts | — | >99¢ · 100¢ (<1¢) | — | ended |
| AS Omónoia Leukosías 2nd Half O/U 2.5 | 0% | −46 pts | −49 pts | — · <1¢ | — | ended |
| AS Omónoia Leukosías 2nd Half O/U 3.5 | 0% | −49 pts | −49 pts | — · <1¢ | — | ended |
| When | Trader | Outcome | Bet | Size | P&L now | Insider |
|---|---|---|---|---|---|---|
| 1d | Winning2... | O/U 2.5 | SellOver>99¢ | $1,998 | −$2 −0.1% | — |
| 1d | Cwy00000 | O/U 1.5 | SellOver>99¢ | $1,956 | −$2 −0.1% | — |
| 1d | 0x8807…f908 | O/U 1.5 | SellOver>99¢ | $1,022 | −$4 −0.4% | — |
| 1d | GoalLineGhost | O/U 3.5 | BuyUnder81¢ → 100¢ | $1,568 | +$368 +23% | 4 |
| 1d | 0x8191…da72 | O/U 3.5 | BuyUnder69¢ → 100¢ | $1,816 | +$816 +45% | 4 |
| 1d | Cwy00000 | O/U 1.5 | BuyOver83¢ → 100¢ | $1,755 | +$359 +20% | 4 |
| 2d | ferrariChampions2026 | O/U 2.5 | BuyOver52¢ → 100¢ | $1,840 | +$1,698 +92% | 14 |
Impassioned-Pruner120 sharesMore markets for the UEFA Europa League game, scheduled for October 15 at 12:45 PM ET.
Sources: Polymarket's Gamma API, its CLOB price history and its Data API, read every two minutes. Prices are each outcome's Yes price, which is the market's probability: 100¢ for O/U 2.5 means the market gives it about 100%.